The unchallenged point here is that there is a significant legal distinction between a brand drug that has been FDA-approved (and therefore compatible with 10 U.S.C. § 1107a), and a drug that continues to be identified (by Pfizer itself, mind you) as experimental, i.e., "received an EUA from the...